MedPath

the study is to compare the intubating conditions between succinylcholine, the gold standard drug for rapid sequence induction and rocuronium after treatment with magnesium sulphate which makes the action of rocuronium similar to that of succinylcholine

Not yet recruiting
Conditions
Age18-60 yearsASA physical status I & IIBody mass index 18.5-24.9 kg/m2Mallampati grade 1 & 2surgery under general anaesthesia
Registration Number
CTRI/2022/11/046959
Lead Sponsor
ABVIMS Dr RML Hospital
Brief Summary

Trial not yet started

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

ASA physical status I & II Body mass index 18.5-24.9 kg/m2 Mallampati grade 1 & 2 surgery under general anaesthesia.

Exclusion Criteria

refusal of consent emergency surgery anticipated difficult airway pregnant or breastfeeding patients patients with hepatic, renal metabolic or neuromuscular disorders allergic to study drugs patients receiving drugs that influence neuromuscular functions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the intubating conditions during rapid sequence intubation using Coopers criteriaintubating conditions will be graded as | 8-9 : excellent | 6-7 :good | 3-5:fair | 0-2:poor
Secondary Outcome Measures
NameTimeMethod
1.To study the hemodynamic parameters:heart rate,systolic,diastolic blood pressure amd mean arterial pressure,Sp02 in both groups at following intervals2.To study the side effects : muscle pain, burning sensation,nausea,vomiting

Trial Locations

Locations (1)

ABVIMS & Dr RML Hospital

🇮🇳

Central, DELHI, India

ABVIMS & Dr RML Hospital
🇮🇳Central, DELHI, India
nivedha
Principal investigator
08072533653
nivedha196@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.